GeneDx is a leading global clinical laboratory that offers testing for screening and diagnosing both common and rare genetic disorders.
GeneDx offers targeted genetic panels, whole-genome, and whole-exome testing for patients and their families to identify genetic biomarkers for both common and rare diseases and disorders.
Working together since 2012, GeneDx entrusted LEAP with the development and launch of their large-scale Hereditary Cancer screening program.
Large-batch Hereditary Cancer screening program for pre-test and post-result genetic counseling
Leveraged both digital and analog processes
Designed high-throughput, integrated digital workflows for multi-divisional scientific, clinical, operational, compliance, revenue-cycle, and software teams
Launched patient and clinician content platforms and decision support tools for testing to ensure reimbursement
Standardized clinical and lab systems
Operationalized procedures
Adapted systems to support migration from individual to multi-patient-batch testing
Automated lab and administrative processes
Integrated ordering and scheduling with clients’ electronic medical records systems
Created digital revenue cycle programs that automate prior authorizations, claim appeals, and other important revenue-cycle initiatives
Advised on software and data considerations for HIPAA and CLIA clinical lab workflow systems and genetic data biobanking
Enabled high-performance-computing for genetic sequencing, high-volume and semi-automated variant annotation and report-writing workflows
Patient-friendly reporting tools and genetic counseling programs
Client-accessible population analytics and cohort analysis for research
Identified partnerships in IT, bioinformatics, automation, RCM, digital agencies
Operated outsourced strategic software/workflow innovation team for the CIO
Partnered with cross-teams on ongoing roadmap of new processes and products
.svg)
.svg)
